These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 387371)

  • 41. The influence of the injection site on the bioavailability of ampicillin and amoxycillin in beagles.
    ten Voorde G; Broeze J; Hartman EG; van Gogh H
    Vet Q; 1990 Apr; 12(2):73-9. PubMed ID: 2363241
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative activity of amoxycillin and ampicillin in an experimental bacterial infection in mice.
    Hunter PA; Rolinson GN; Witting DA
    Antimicrob Agents Chemother; 1973 Sep; 4(3):285-93. PubMed ID: 4586142
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Amoxycillin/clavulanic acid ('Augmentin') compared with a combination of aminopenicillin, aminoglycoside and metronidazole in the treatment of pelvic inflammatory disease.
    Cirau-Vigneron N; Barrier J; Becue J; Chartier M; Giraud JR; Landes P; Leng J; Raudrant D; Reme JM
    Pharmatherapeutica; 1989; 5(5):312-9. PubMed ID: 2664816
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fosfomycin trometamol versus amoxycillin--single-dose multicenter study of urinary tract infections.
    Neu HC
    Chemotherapy; 1990; 36 Suppl 1():19-23. PubMed ID: 2085982
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of amino penicillins in experimental infections in mice.
    Forsgren U; Ekström B; Jalar LP; Magni L
    Scand J Infect Dis Suppl; 1978; (14):207-13. PubMed ID: 279973
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and tolerability of an amoxycillin/clavulanic acid combination in the treatment of common bacterial infections. A general practitioner trial.
    Levenstein JH
    S Afr Med J; 1982 Jul; 62(5 Spec No):16A-20A. PubMed ID: 7046104
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1979 Jan; 17(1):1-37. PubMed ID: 369806
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Amoxycillin and ampicillin. A comparative study of in vitro sensitivity and induced morphological alterations in Serratia marcescens.
    Miller MA; Kuemmerle NB; Gentile G
    Jpn J Microbiol; 1975 Jun; 19(3):219-24. PubMed ID: 1100890
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparative study of amoxycillin and pivampicillin in persistent Haemophilus influenzae infection of the lower respiratory tract in children with chronic lung disease.
    Pedersen M; Støvring S; Mørkassel E; Koch C; Høiby N
    Scand J Infect Dis; 1986; 18(3):245-54. PubMed ID: 3526532
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Amoxycillin absorption and penetration in pelvic inflammatory disease.
    Onsrud M; Gjønnaess H; Bergan T
    Acta Obstet Gynecol Scand; 1979; 58(4):401-3. PubMed ID: 525275
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparative trial of amoxycillin 3g bd and conventional amoxycillin therapy in the treatment of urinary tract infection in a general practice population.
    Abbas AM; Goel PK; Smaling AP; Davey A; Ancill RJ
    J Antimicrob Chemother; 1983 Jun; 11(6):593-6. PubMed ID: 6885683
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use.
    Carmine AA; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1983 Mar; 25(3):223-89. PubMed ID: 6303743
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The in vitro activity of amoxycillin with clavulanic acid against clinically significant bacteria. A multicentre study.
    Van den Ende J; Gricius ME; De Klerk HC; Neiteler BF; Forder AA; Venter L; Hallett AF; Koornhof HJ; Robinson R; Van Rensburg AJ; Lindeque KP
    S Afr Med J; 1982 Jul; 62(5 Spec No):5A-8A. PubMed ID: 6979805
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of amoxycillin and cefaclor on the colonization resistance of oropharynx.
    van Saene HK; Willems FT; Zweens J
    Scand J Infect Dis Suppl; 1983; 39():97-9. PubMed ID: 6359384
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical experience with intravenous Augmentin in the treatment of paediatric infections.
    Ploechl E; Huber EG
    J Int Med Res; 1986; 14(3):153-7. PubMed ID: 3636248
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Pharmacokinetics and clinical aspects of a new ampicillin].
    Di Nola F; Soranzo ML; Sachelariu N; Bosio G; Marietti G; Mastroviti S
    Minerva Med; 1977 Feb; 68(9):569-86. PubMed ID: 321993
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amoxycillin: pharmacokinetic studies in normal subjects, patients with pernicious anaemia and those with renal failure.
    Lawson DH; Henderson AK; McGeachy RR
    Postgrad Med J; 1974 Aug; 50(586):500-3. PubMed ID: 4618910
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Fundamental studies on aspoxicillin in the field of gynecology. Penetration of the drug into the genital organs and the dead space fluid. Antibacterial activity of the drug against various strains of clinical isolates].
    Takase Z; Shirafuji H; Maki M; Seki M; Cho N; Noda K; Hayasaki M; Itoh K; Hasegawa Y; Ninomiya K
    Jpn J Antibiot; 1985 Jul; 38(7):1979-2002. PubMed ID: 3851864
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative pharmacokinetic analysis of amoxycillin using open two and three-compartment models.
    Dalhoff A; Koeppe P
    Eur J Clin Pharmacol; 1982; 22(3):273-9. PubMed ID: 7106161
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biodegradable periodontal intrapocket device containing metronidazole and amoxycillin: formulation and characterisation.
    Ahuja A; Ali J; Rahman S
    Pharmazie; 2006 Jan; 61(1):25-9. PubMed ID: 16454202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.